3,616
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression and chemoresistance by enhancing the secretion of chemotherapy-induced senescence-associated secretory phenotype via activation of DNA damage response pathway

, , , , , & show all
Article: 2197836 | Received 07 Aug 2022, Accepted 28 Mar 2023, Published online: 05 Apr 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chun Ye, Xiao Liu, Zilun Liu, Chuxuan Pan, Xiaowei Zhang, Zhanyi Zhao & Haitao Sun. (2024) Fusobacterium nucleatum in tumors: from tumorigenesis to tumor metastasis and tumor resistance. Cancer Biology & Therapy 25:1.
Read now

Articles from other publishers (5)

Jakub Makarewicz, Karolina Kaźmierczak-Siedlecka, Bartosz Kamil Sobocki, Iwona T. Dobrucki, Leszek Kalinowski & Ewa Stachowska. (2024) Anti-cancer management of head and neck cancers and oral microbiome—what can we clinically obtain?. Frontiers in Cellular and Infection Microbiology 14.
Crossref
Kui Wang, Jiawei Wang, Yuhua Chen, Huan Long, Wei Pan, Yunfei Liu, Ming-Yi Xu & Qiang Guo. (2024) Causal relationship between gut microbiota and risk of esophageal cancer: evidence from Mendelian randomization study. Aging 16:4, pages 3596-3611.
Crossref
Xingqiang Huang, Xueyi Chen, Guowei Wan, Dandan Yang, Dongqiang Zhu, Linqian Jia & Jinping Zheng. (2024) Mechanism of intestinal microbiota disturbance promoting the occurrence and development of esophageal squamous cell carcinoma——based on microbiomics and metabolomics. BMC Cancer 24:1.
Crossref
Ziyi Liu, Yige Ma, Jinxin Ye, Guofeng Li, Xiaoxu Kang, Wensheng Xie & Xing Wang. (2024) Drug delivery systems for enhanced tumour treatment by eliminating intra-tumoral bacteria. Journal of Materials Chemistry B 12:5, pages 1194-1207.
Crossref
Nicolas Guillot, Barnabé Roméo, Shima Sepehri Manesh, Gerard Milano, Patrick Brest, Laurence Zitvogel, Paul Hofman & Baharia Mograbi. (2023) Manipulating the gut and tumor microbiota for immune checkpoint inhibitor therapy: from dream to reality. Trends in Molecular Medicine 29:11, pages 897-911.
Crossref